Linisan (Citalopram Hydrobromide)

Citalopram blocks the serotonin transporter on presynaptic neurons, preventing reuptake of serotonin from the synaptic cleft. This raises extracellular serotonin levels, enhancing serotonergic signaling in brain circuits that regulate mood, anxiety, and cognition, which contributes to its antidepressant and anxiolytic actions.

The appropriate dose of Linisan is determined by the prescribing clinician based on the individual’s medical condition, age, response to therapy, and any concomitant medications. Dosage adjustments may be required for special populations, and patients should follow the prescriber’s instructions without self‑adjusting the dose.

Safety data for citalopram during pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against possible risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their physician before initiating or continuing Linisan.

To request Linisan, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Linisan belongs to the SSRI class, which generally offers a favorable side‑effect profile compared with older tricyclic antidepressants and monoamine oxidase inhibitors. Compared with other SSRIs, citalopram has a relatively selective effect on serotonin reuptake and a lower affinity for other receptors, though individual response and tolerability can vary.

Linisan tablets should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use after the expiration date printed on the label.

Linisan is taken orally, usually once daily with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious risks include serotonin syndrome—a potentially life‑threatening condition characterized by agitation, hyperthermia, and muscle rigidity—and cardiac arrhythmias due to QT interval prolongation. Patients should also be monitored for emerging suicidal thoughts, especially during the early weeks of therapy.

Linisan is contraindicated in individuals who have a known hypersensitivity to citalopram or any component of the formulation, and in patients currently taking monoamine oxidase inhibitors. Caution is advised for those with a history of cardiac conduction abnormalities, uncontrolled electrolyte disturbances, or severe hepatic impairment.